	Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology. JCO Precis Oncol Kamran SC, Borges M, Michalski J, Lee WR, Sandler HM, Crook J, Pollack A, Hurwitz MD, Valicenti RK, Bruner DW, Lukka H, Jones CU, Roach M 3rd, Lawton C, Rosenthal SA, Pisansky TM, Spratt D, Vapiwala N, Efstathiou J, Miyamoto D, Mouw K, Vyfhuis M, Le QT, Willers H, Van Allen E, Huang F, Bahary JP, Helou J, Pugh SL, Wenzel J, Tran P. PMID: 42418740 [PubMed - indexed for MEDLINE]
	Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials. JCO Precis Oncol Sweeney CJ, Krishna V, Krishna V, Neema A, Tarsode A, Subhash VV, Horvath LG, Kench JG, Stockler MR, Yip S, Thomas H, Swami U, Zhang H, Sonawane S, Abuzeid WM, Nimgaonkar V, Tiu E, Watson D, Kiedrowski L, Royce TJ, Yang DD, Tran PT, Ryan CJ, Nguyen PL, Morgans AK, Joshi A, Agarwal N, Davis ID. PMID: 42418739 [PubMed - indexed for MEDLINE]
	Shallow Whole-Genome Sequencing to Assess Genomic Instability and Predict Treatment Response in Metastatic Castration-Resistant Prostate Cancer. JCO Precis Oncol Slootbeek PHJ, Quint YM, Kokke JJR, Pamidimarri Naga S, Luna-Velez MV, Ligtenberg MJL, de Voer RM, Mehra N. PMID: 42418738 [PubMed - indexed for MEDLINE]
	Informed Decision Making for Prostate Cancer Screening - A Prospective, Randomized Study of Two Novel Web-based, Electronic Visits. J Urol Presti J Jr, Prausnitz S, Altschuler A, Horton B, Alexeeff S, Avins AL. PMID: 42418618 [PubMed - as supplied by publisher]
	Multimodal imaging to analyze the biomechanical properties of kidney tumors, evaluating feasibility, inter-modality correspondence, and diagnostic value (UroCCR-115). PLoS One Ronca M, Conforti P, Crombé A, Jaffredo M, Ricard S, Colin T, Yacoub M, Le Bras Y, Bernhard JC, Margue G, Fourage-Jambon E. PMID: 42418537 [PubMed - indexed for MEDLINE]
	Development and Advantages of O-(Carboxymethyl)-L-tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer. J Med Chem Li L, Zhao R, Wang G, Jin W, Zhu L, Zhu Z, Kung HF. PMID: 42418373 [PubMed - as supplied by publisher]
	Same-day Hyaluronic Acid rectal spacer for TRUS-guided HDR Prostate Brachytherapy: Feasibility and dosimetric outcomes. J Appl Clin Med Phys Ng SK, Pokhrel D, Huang C, Asamoah FA, Holmes JA, Prabhu A, Ishaq O. PMID: 42418218 [PubMed - indexed for MEDLINE]
	Dual Marker Co-Expressed Exosome-Based Liquid Biopsy Electrochemical Assay for Enhanced-Accuracy Diagnosis of Prostate Cancer. ACS Sens Wei F, Jiang Q, Chen W, Chen F, Zhang M, Yu Y, Guan M, Li S. PMID: 42418184 [PubMed - as supplied by publisher]
	Impact of prostate mpMRI quality on diagnostic accuracy in prostate cancer: a prospective study. BJU Int Cannoletta D, Brembilla G, Longoni M, Porzi ME, Quarta L, Santangelo A, Scilipoti P, Zaurito P, Brancaccio M, Scuderi S, Barletta F, Cosenza M, Gandaglia G, Montorsi F, De Cobelli F, Briganti A, Stabile A. PMID: 42417115 [PubMed - as supplied by publisher]
	Endocrine-driven inflammatory-epigenetic adaptation as a proposed axis of radioresistance in endocrine-exposed prostate cancer: a translational hypothesis. Front Endocrinol (Lausanne) Gruji, , Alaverdashvili T, Eroglu I, Krasi, Jankovi, Milosavljevi. PMID: 42416899 [PubMed - indexed for MEDLINE]
	Superior cancer detection with transperineal biopsy in patients with an elevated prostate-specific antigen level and a PI-RADS score of 3-4: A retrospective cohort study. Oncol Lett Zhang J, Zheng H. PMID: 42416028 [PubMed]
	Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer. Nanomedicine (Lond) Pan CX, Mossanen M, Ellis JL, Ma AH, Yang C, Farrukh H, Jiao Y, Bhardwaj U, Lee JS, Lara PN, Hynes C, Lin TY, Li Y, Lerner L, Preston MA, Kibel A, Dall'Era M, Lam KS. PMID: 42415671 [PubMed - as supplied by publisher]
	Early clinical experience and learning curve of transperineal prostate biopsy with a novel angle-adjustable needle guide. Can J Urol Öztürk E, Uzel T, I, Da, Ham, Ba. PMID: 42415591 [PubMed - indexed for MEDLINE]
	External validation of the heidenreich criteria for patients with post-chemotherapy residual masses of non-seminomatous germ cell tumor. Can J Urol Claps F, Ramírez-Backhaus M, Gómez-Ferrer Á, Mascarós JM, Collado Serra A, Wong A, Calatrava Fons A, Climent MÁ, Amodeo A, Porreca A, Rubio-Briones J. PMID: 42415580 [PubMed - indexed for MEDLINE]
	Clinical and racial predictors of adverse pathology at radical prostatectomy: implications for undertreatment among patients receiving radiation and hormonal therapy. Can J Urol Sayan M, Tuac Y, Qian Z, Cole AP, Leeman JE, King MT, Nguyen PL, D'Amico AV. PMID: 42415579 [PubMed - indexed for MEDLINE]
	Aquablation for LUTS due to BPH in men with localized prostate cancer. Can J Urol Kearns JT, Chang C, Wang C, Ward C, Dunnenberger HM, Novakovic K, Glaser AP, Helfand BT. PMID: 42415576 [PubMed - indexed for MEDLINE]
	Understanding the utilization of genetic counseling and testing among patients with prostate cancer. Can J Urol Morton EA, Lahiji R, Chu E, Luke W, Anyaeche VI, Patil D, Mehta A, Joshi SS, Goodstein TA, Grajales V, Hajiha M. PMID: 42415575 [PubMed - indexed for MEDLINE]
	A computer-aided diagnosis tool in prostate cancer patients with biochemical recurrence using 18F-PSMA PET/CT imaging. Med Phys Stamouli I, Gatos I, Kalathas T, Tsantis S, Zoglopitou LA, Katsakiori PF, Papathanasiou N, Makridou A, Chatzipavlidou V, Hazle JD, Kagadis GC. PMID: 42415410 [PubMed - indexed for MEDLINE]
	Longitudinal CT number characterization of a novel upright CT for proton therapy planning. J Appl Clin Med Phys Yan Y, Slagowski JM, Miller JR, Hayes JW, Kang M, Hoffman CA, Glide-Hurst CK. PMID: 42415297 [PubMed - indexed for MEDLINE]
	Exploring Genetic Contributions to Prostate Cancer Risk in an Asian Population-Based Study. Cancer Med Geng JH, Yu CC, Huang CY, Lin VC, Li CY, Wu MT, Chen SC, Bao BY, Huang SP. PMID: 42415294 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 179847

Page 1 of 8993



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy